Decline in bilirubin at 4 to 8 hours (μmol/L) · newborn infants with unconjugated hyperbilirubinaemia
1 finding from 1 review
Decline in serum bilirubin (over 24 hours) · newborn infants with unconjugated hyperbilirubinaemia
1 finding from 1 review
Exchange transfusion · newborn infants with unconjugated hyperbilirubinaemia
1 finding from 1 review
Acute life‐threatening events · newborn infants with unconjugated hyperbilirubinaemia
1 finding from 1 review
Parental satisfaction · newborn infants with unconjugated hyperbilirubinaemia
1 finding from 1 review
Breastfeeding ondischarge · newborn infants with unconjugated hyperbilirubinaemia
1 finding from 1 review
Adverse events · patients with non‐specific acute and subacute low back pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain intensity various scales short‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Pain: intermediate‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Disability Multiple scales (0 to 100) Short‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Disability (intermediate‐term) RMDQ. Scale from: 0 to 24. · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Dental caries prevalence and severity · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in dental caries/severity between ART regimens (very low certainty).
1 finding from 1 review
Angular cheilitis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No eligible studies compared angular cheilitis between different ART regimens.
1 finding from 1 review
Recurrent oral ulceration prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in recurrent oral ulceration between ART regimens (very low certainty).
1 finding from 1 review
Dental development and maturation · Children and adolescents (<18 years) living with HIV (CLWH)
No eligible studies compared dental development and maturation between different ART regimens.
1 finding from 1 review
Acute necrotising ulcerative periodontitis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in acute necrotising ulcerative periodontitis between ART regimens (very low certainty).
1 finding from 1 review
Kaposi's sarcoma prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in kaposi's sarcoma between ART regimens (very low certainty).
1 finding from 1 review
Linear gingival erythema prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in linear gingival erythema between ART regimens (very low certainty).
1 finding from 1 review
Chronic herpes simplex infection prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in chronic herpes simplex infection between ART regimens (very low certainty).
1 finding from 1 review
Efficacy (functional outcome) · stroke and/or TIA
It is very uncertain whether marine‐derived n‐3 fatty acids therapy changes primary outcome: efficacy (functional outcome) compared with no marine‐derived n‐3 fatty acids therapy (very low certainty).
2 findings from 1 review